Health Robotics Expands i.v.STATION® Footprint in North America with Children's Hospital of Los Angeles
Share:
BOZEN, SUD-TIROL, Italy, -- Health Robotics today announced its first 2011 contract for the installation of 2 i.v.STATION robots at Children's Hospital of Los Angeles, marking the third California hospital, after Cottage Health System and Memorial Care, to purchase 2 i.v.STATIONs each. The installation of the 2 i.v.STATIONs is scheduled to occur during 1Q2011 initially focusing on antibiotics and controlled substances, and in conjunction with Health Robotics' i.v.SOFT Assist Workflow Engine for Chemotherapy. Finally, this new agreement also represents the third i.v.STATION for Pediatrics sold in the United States of America, after Miller Children's Hospital in Long Beach.
"The worldwide recognition of Children's Hospital of Los Angeles'outstanding quality and experience carries a great deal of importance for Health Robotics and its continued global dominance of the IV Automation Sector. I'm particularly pleased that Children's Hospital of Los Angeles compared and verified i.v.STATION's superior R.O.I., throughput, and high-availability features after site visits to Cottage Health System for i.v.STATION, and a competitor's solution [RIVA] installed at another nearby Southern California pediatric institution. Everyone at Health Robotics is very proud of our American partners' [McKesson and HRCI] continued support, thus enabling such a great American kick-off for the company in 2011" stated Gaspar DeViedma, Health Robotics' Executive Vice President.
i.v.STATION's $275,000 price, combined with its plug-and-play installation, flexibility for bags' and syringes' brands and sizes, ISO-5 controlled environment, and unprecedented robotic throughput, has already revolutionized Non-Hazardous Sterile Compounding in North America. Multiple hospital studies have proven an i.v.STATION's 3-to-1 cost advantage over Pre-Mix/Frozen solutions by Baxter, B. Braun, and Hospira, and also consistently revealed a 6-to-1 cost advantage over outsourced custom IV manufacturing offered by Ameridose, CAPS, and PharMEDium in multiple North American local markets. Furthermore, i.v.STATION/RIVA comparison studies have shown public evidence that i.v.STATION is 4 times faster than RIVA. When factoring in RIVA's $1M+ higher price, i.v.STATION is 20 times less expensive than RIVA on a per-dose basis.
About Children's Hospital Los Angeles:
Founded in 1901, Children's Hospital Los Angeles is one of the nation's leading children's hospitals and is acknowledged worldwide for its leadership in pediatric and adolescent health. Children's Hospital Los Angeles is one of only seven children's hospitals in the nation - and the only children's hospital on the West Coast - ranked for two consecutive years in all 10 pediatric specialties in the U.S. News & World Report rankings and named to the magazine's "Honor Roll" of children's hospitals. The Saban Research Institute at Children's Hospital Los Angeles is among the largest and most productive pediatric research facilities in the United States, with 100 investigators at work on 186 laboratory studies, clinical trials and community-based research and health services. The Saban Research Institute is ranked eighth in National Institutes of Health funding among children's hospitals in the United States. Children's Hospital Los Angeles is a premier teaching hospital and has been affiliated with the Keck School of Medicine of the University of Southern California since 1932.
About Health Robotics:
Health Robotics is the undisputed global leading supplier of life-critical intra-venous medication robots, providing healthcare facilities in 5 continents with robotics technology and software automation solutions deployed utilizing virtual high-availability technology. Its world-leading solutions CytoCare® [hazardous IVs], i.v.STATION® [non-hazardous IVs], i.v.SOFT® [manual compounding software], MEDarchiver® [clinical information system], and TPNstation(TM) [totally-automated parenteral nutrition] have and will greatly contribute to ease hospitals' growing pressures to improve patient safety, increase throughput and contain costs. Through the effective and efficient production of sterile, accurate, tamper-evident and ready-to-administer IVs, Health Robotics' solutions help hospitals eliminate life-threatening drug-exchange errors, decrease other medical errors and sterility risks, work more efficiently, reduce waste and controlled substances' diversion, and diminish the gap between rising patient volume/acuity and scarce medical, nursing, and pharmacy staff. For more company information, please visit http://www.health-robotics.com/
For additional information, please contact:
Claudia Flaim, Marketing Coordinator
flaim@health-robotics.com
Phone: +39-0471-200-372
Source: Health Robotics
